IMPLENIA N (Switzerland) Today

IMPN -  Switzerland Stock  

CHF 23.58  0.54  2.34%

IMPLENIA N is selling for under 23.58 as of the 28th of July 2021; that is 2.34 percent up since the beginning of the trading day. The stock's lowest day price was 22.92. IMPLENIA N has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for IMPLENIA N are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of August 2019 and ending today, the 28th of July 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Over 73
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

IMPLENIA N Stock Profile

Implenia AG operates as a construction and real estate services company primarily in Switzerland, Germany, Austria, Norway, Sweden, France, and internationally. Implenia AG was founded in 2006 and is headquartered in Dietlikon, Switzerland. IMPLENIA N operates under Engineering Construction classification in Switzerland and is traded on Switzerland Exchange. It employs 8701 people. more on IMPLENIA N
IMPLENIA N generates negative expected return over the last 90 days
IMPLENIA N has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 3.99 B. Net Loss for the year was (134.7 M) with profit before overhead, payroll, taxes, and interest of 1.23 B.
IMPLENIA N has accumulated about 719.99 M in cash with (161.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 39.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 33.0% of the company shares are held by company insiders
Legal NameIMPLENIA N
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of IMPLENIA N's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
IMPLENIA N (IMPN) is traded on Switzerland Exchange in Switzerland and employs 8,701 people. The company currently falls under 'Small-Cap' category with current market capitalization of 434.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate IMPLENIA N's market, we take the total number of its shares issued and multiply it by IMPLENIA N's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. IMPLENIA N operates under Industrials sector and is part of Engineering & Construction industry. The entity has 18.44 M outstanding shares. IMPLENIA N has accumulated about 719.99 M in cash with (161.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 39.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check IMPLENIA N Probability Of Bankruptcy
Ownership
IMPLENIA N secures a total of 18.44 Million outstanding shares. IMPLENIA N secures noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check IMPLENIA Ownership Details

IMPLENIA Stock Price Odds Analysis

What are IMPLENIA N's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of IMPLENIA N jumping above the current price in 90 days from now is about 80.3%. The IMPLENIA N probability density function shows the probability of IMPLENIA N stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon IMPLENIA N has a beta of -0.2664. This usually indicates as returns on benchmark increase, returns on holding IMPLENIA N are expected to decrease at a much lower rate. During the bear market, however, IMPLENIA N is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. IMPLENIA N is significantly underperforming DOW.
 Odds Down 23.58HorizonTargetOdds Up 23.58 
19.53%90 days
 23.58 
80.30%
Based on a normal probability distribution, the odds of IMPLENIA N to move above the current price in 90 days from now is about 80.3 (This IMPLENIA N probability density function shows the probability of IMPLENIA Stock to fall within a particular range of prices over 90 days) .

IMPLENIA N Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. IMPLENIA N market risk premium is the additional return an investor will receive from holding IMPLENIA N long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IMPLENIA N. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although IMPLENIA N's alpha and beta are two of the key measurements used to evaluate IMPLENIA N's performance over the market, the standard measures of volatility play an important role as well.

IMPLENIA Stock Against Markets

Picking the right benchmark for IMPLENIA N stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in IMPLENIA N stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for IMPLENIA N is critical whether you are bullish or bearish towards IMPLENIA N at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in IMPLENIA N without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module
Please see Risk vs Return Analysis. Note that the IMPLENIA N information on this page should be used as a complementary analysis to other IMPLENIA N's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Tools for IMPLENIA Stock

When running IMPLENIA N price analysis, check to measure IMPLENIA N's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IMPLENIA N is operating at the current time. Most of IMPLENIA N's value examination focuses on studying past and present price action to predict the probability of IMPLENIA N's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move IMPLENIA N's price. Additionally, you may evaluate how the addition of IMPLENIA N to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go